Jean Bizzari

Jean Bizzari

Director/Board Member at ADC THERAPEUTICS SA

Net worth: 3 M $ as of 2024-03-30

69 year
Health Technology
Commercial Services
Process Industries

Profile

Jean Pierre Bizzari is currently the Chairman of NETRIS Pharma SAS, Director at Oxford BioTherapeutics Ltd., President & Director of Synergie Lyon Cancer, Director of the European Organisation for Research & Treatment of Cancer, Non-Executive Director of the International Drug Development Institute SA, Non-Executive Director of ADC Therapeutics SA, and Director of Aprea Therapeutics, Inc. He previously served as a Director at Compugen Ltd.
from 2018 to 2022, Director at Transgene SA from 2008 to 2012, Independent Director at Celator Pharmaceuticals, Inc. from 2015 to 2016, Independent Director at Valerio Therapeutics SA, Independent Director at Nordic Nanovector ASA, Director at Theravectys SAS, Director at iTeos Therapeutics SA, Independent Director at Pieris Pharmaceuticals, Inc. from 2015 to 2020, Independent Director at Halozyme Therapeutics, Inc. from 2015 to 2024, Executive Vice President & Global Head-Oncology at Celgene Corp.
from 2012 to 2015, Vice President-Clinical Development at Aventis, Inc., Vice President-Clinical Development Oncology at Rhone Poulenc Rorer from 1993 to 1997, Vice President-Clinical Development Oncology at Sanofi-Synthelabo, Inc. from 2002 to 2004, Vice President-Clinical Oncology at Rhône-Poulenc, Inc. from 1993 to 2002, Vice President-Clinical Oncology Development at Sanofi-Aventis Pharmaceuticals from 2004 to 2008, and Head-Oncology at Institut de Recherches Internationales Servier.
He holds graduate and doctorate degrees from the University of Nice Sophia Antipolis.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-25 58,750 ( 0.05% ) 2 M $ 2024-03-30
2024-01-31 39,387 ( 0.05% ) 176 848 $ 2024-03-30

Jean Bizzari active positions

CompaniesPositionStart
ADC THERAPEUTICS SA Director/Board Member 2022-06-30
APREA THERAPEUTICS, INC. Director/Board Member 2023-08-22
Chairman -
Director/Board Member -
President -
Director/Board Member 2016-12-15
European Organisation for Research & Treatment of Cancer Director/Board Member -
All active positions of Jean Bizzari

Former positions of Jean Bizzari

CompaniesPositionEnd
HALOZYME THERAPEUTICS, INC. Director/Board Member 2024-04-24
COMPUGEN LTD. Director/Board Member 2022-02-28
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Jean Bizzari's experience

Training of Jean Bizzari

University of Nice Sophia Antipolis Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jean Bizzari's experience

Connections

100 +

1st degree connections

24

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies7
COMPUGEN LTD.

Health Technology

HALOZYME THERAPEUTICS, INC.

Health Technology

TRANSGENE

Health Technology

VALERIO THERAPEUTICS

Health Technology

ADC THERAPEUTICS SA

Health Technology

PIERIS PHARMACEUTICALS, INC.

Health Technology

APREA THERAPEUTICS, INC.

Health Technology

Private companies16

Health Technology

Aventis, Inc.

Health Technology

Health Technology

Process Industries

Sanofi-Synthelabo, Inc.

Health Technology

Rhône-Poulenc, Inc.

Process Industries

Sanofi-Aventis Pharmaceuticals

Commercial Services

European Organisation for Research & Treatment of Cancer

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

See company connections